- Report
- February 2025
- 214 Pages
Global
From €2281EUR$2,500USD£1,961GBP
- Report
- October 2024
- 197 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 197 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- April 2025
- 200 Pages
Global
From €2272EUR$2,490USD£1,954GBP
- Report
- October 2024
- 100 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- April 2025
- 363 Pages
Global
From €4972EUR$5,450USD£4,276GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- November 2024
- 150 Pages
Global
From €4425EUR$4,850USD£3,805GBP
- Report
- July 2024
- 147 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- December 2024
- 200 Pages
Global
From €3421EUR$3,750USD£2,942GBP
- Report
- January 2025
- 180 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- July 2022
Global
From €2395EUR$2,625USD£2,059GBP
€4790EUR$5,250USD£4,119GBP
- Report
- July 2023
- 115 Pages
Global
From €3512EUR$3,850USD£3,021GBP
- Report
- August 2023
- 150 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- October 2023
- 170 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- April 2023
- 84 Pages
Europe
From €3649EUR$4,000USD£3,138GBP
- Report
- February 2024
- 112 Pages
Global
From €4333EUR$4,750USD£3,727GBP
- Report
- April 2023
- 110 Pages
Global
From €4333EUR$4,750USD£3,727GBP
- Report
- August 2022
- 120 Pages
Global
From €4333EUR$4,750USD£3,727GBP
- Report
- August 2022
- 122 Pages
Global
From €4333EUR$4,750USD£3,727GBP

Central Nervous System (CNS) Stimulants are a class of drugs used to treat a variety of conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. These drugs work by increasing the activity of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which can improve focus and alertness. Common side effects of CNS stimulants include insomnia, anxiety, and increased heart rate.
CNS stimulants are typically prescribed by a doctor and are available in both short- and long-acting forms. Short-acting forms are taken as needed, while long-acting forms are taken once daily. These drugs are generally considered safe when taken as prescribed, but they can be abused and can lead to addiction.
Some of the major companies in the CNS stimulants market include Shire, Novartis, Johnson & Johnson, Pfizer, and GlaxoSmithKline. These companies produce a variety of CNS stimulants, including methylphenidate, amphetamine, and lisdexamfetamine. Show Less Read more